Again, I apologize. I don't have that report right in front of me to pull those numbers. There are a few important factors. One is that right now we are outsourcing the responsibility of pharmacare either onto the individual or onto businesses. There are a lot of employers who supply supplementary health benefits that pay for pharmaceuticals. I think that right now, across the board, what we are seeing is a significant increase to those costs for employers, and of course that will disproportionately affect smaller employers. Our taking on this responsibility to provide quality health care collectively will mean that employers will save that money, which, especially for medium and small businesses, will mean that they turn around and have more cash flow, which is helpful. But it also means that, when people are taking their recommended medication and what is required for them to live a healthy life, it is less of a burden on our health care system.
I will also send you the report I am referring to, and I apologize that I didn't bring it with me. It does go into detail that, although it looks like an expensive system, when you look at where we are spending and overspending, which is in emergent care and long-term care.... When people are unable to take their medications and follow the doctor's orders, that is very expensive for our system, or we are not dealing with it until it's very severe. There is a price tag connected to that, and it's very high.
When you look at the comprehensive system overall, you see that pharmacare outside of hospitals is a very important part in order to ensure that we are keeping our health care at a responsible cost and we are getting value for it.